Brazil

BMI View: The Brazilian government's good pharmaceutical practice programme will moderately improve the efficiency of the country's public pharmaceutical distribution system. However,... 2012-05-04

BMI Core View: Emerging markets will drive industry growth. The importance of emerging markets to large multinational drugmakers cannot be overstated and BMI's Pharmaceutical Expenditure... 2012-04-24

BMI View: The Brazilian government is increasing investment in the healthcare sector to reduce the financial burden of diseases on local citizens and trade deficit, as well as to stimulate... 2012-04-20

BMI Core View: Governments in emerging markets are increasing investment in local biopharmaceutical research and development (R&D) as they become increasingly aware of the importance... 2012-04-19

BMI View: The Brazilian government is determined to promote the local pharmaceutical industry through direct investment and favourable public medicine purchase policies. Multinational... 2012-04-16

BMI View:Pharmaceutical companies in Latin America are seeking regional expansion to increase their competitiveness in the region, with government support of local industry accelerating... 2012-04-12

BMI View: The emerging pharmaceutical market of Brazil offers drugmakers better revenue growth prospects than the mature pharmaceutical markets of the US, Europe and Japan - pushed... 2012-04-11

BMI View: The Brazilian government's promotion of the local pharmaceutical industry will encourage multinational drugmakers to collaborate with domestic producers in order to increase... 2012-04-10

BMI Core View: Emerging markets will drive industry growth. The importance of emerging markets to large multinational drugmakers cannot be overstated and BMI's Pharmaceutical Expenditure... 2012-04-02

BMI View: The joint venture (JV) between four Brazilian drugmakers will potentially increase Hypermarcas' profitability by converting the company into a drug innovator, which will generate... 2012-03-28